Does INSULIN DEGLUDEC Cause Product packaging issue? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Product packaging issue have been filed in association with INSULIN DEGLUDEC (TRESIBA). This represents 0.1% of all adverse event reports for INSULIN DEGLUDEC.
11
Reports of Product packaging issue with INSULIN DEGLUDEC
0.1%
of all INSULIN DEGLUDEC reports
0
Deaths
4
Hospitalizations
How Dangerous Is Product packaging issue From INSULIN DEGLUDEC?
Of the 11 reports, 4 (36.4%) required hospitalization.
Is Product packaging issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INSULIN DEGLUDEC. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does INSULIN DEGLUDEC Cause?
Blood glucose increased (2,644)
Blood glucose decreased (983)
Hypoglycaemia (762)
Nausea (543)
Drug ineffective (449)
Dyspnoea (390)
Vomiting (381)
Stress (368)
Weight increased (364)
Constipation (334)
What Other Drugs Cause Product packaging issue?
ACETAMINOPHEN (448)
LOPERAMIDE (351)
DIMETHICONE\LOPERAMIDE (348)
USTEKINUMAB (221)
FENTANYL (200)
MINOXIDIL (173)
CETIRIZINE (166)
ESTRADIOL (163)
GOLIMUMAB (95)
CYCLOSPORINE (93)
Which INSULIN DEGLUDEC Alternatives Have Lower Product packaging issue Risk?
INSULIN DEGLUDEC vs INSULIN DEGLUDEC\LIRAGLUTIDE
INSULIN DEGLUDEC vs INSULIN DETEMIR
INSULIN DEGLUDEC vs INSULIN GLARGINE
INSULIN DEGLUDEC vs INSULIN GLARGINE-YFGN
INSULIN DEGLUDEC vs INSULIN GLARGINE\LIXISENATIDE